Rectal cancer staging post neoadjuvant therapy – how should the changes be assessed?
- 24 April 2009
- journal article
- Published by Wiley in Histopathology
- Vol. 54 (6) , 713-721
Abstract
Aims: To compare the utility and reproducibility of tumour regression grade scoring systems during histopathological assessment of rectal cancers resected after neoadjuvant (i.e. pre‐operative) chemoradiotherapy.Methods and results: The histopathological features of tumour regression were assessed independently in 54 rectal cancer resection specimens using three scoring systems: the Tumour Regression Grade (TRG), modified Rectal Cancer Regression Grade (m‐RCRG) and RCPath Cancer Dataset (RCPath) methods. Good interobserver agreement was achieved for all three systems (κ scores: TRG system 0.719, m‐RCRG system 0.734, RCPath system 0.742). Both observers diagnosed complete tumour regression and little/no regression in 11 cases (20% of all cases) and four cases (11% of all cases), respectively. A mean of 5.6 tumour blocks/case were taken and the mean lymph node yield was 8.4/case.Conclusions: All three scoring systems were usable in a diagnostic setting. The clinical significance of differing degrees of tumour regression is not yet universally agreed and, with this in mind, the m‐RCRG system provided the optimum balance between applicability and the accurate recording of low, moderate and high degrees of tumour regression, thus facilitating future clinicopathological studies of moderate and high degrees of tumour regression and clinical outcome.Keywords
This publication has 15 references indexed in Scilit:
- The clinical significance of the circumferential resection margin following preoperative pelvic chemo‐radiotherapy in rectal cancer: why we need a common languageColorectal Disease, 2006
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Complexities and controversies in the management of low rectal cancer: Proceedings of the 3rd Pelican Surgical Symposium 2005Colorectal Disease, 2006
- Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal CancerJournal of Clinical Oncology, 2006
- Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancerHistopathology, 2005
- Preoperative Chemoradiotherapy and Total Mesorectal Excision Surgery for Locally Advanced Rectal Cancer: Correlation With Rectal Cancer Regression GradeDiseases of the Colon & Rectum, 2004
- Quantification of Histologic Regression of Rectal Cancer After IrradiationDiseases of the Colon & Rectum, 2002
- Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer, 2002
- Grading and scoring in histopathologyHistopathology, 1998
- Inter‐ and intra‐observer variation in the histopathological reporting of cervical squamous in traepithelial lesion susing a modified Bethesda grading systemBJOG: An International Journal of Obstetrics & Gynaecology, 1998